EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Generation of a Syngeneic Heterozygous ACVRL1(wt/mut) Knockout iPS Cell Line for the In Vitro Study of HHT2-Associated Angiogenesis

Li Xiang-Tischhauser iD, Michael Bette iD, Johanna R Rusche, Katrin Roth, Norio Kasahara iD, Boris A Stuck, Udo Bakowsky iD, Maria Wartenberg, Heinrich Sauer, Urban W Geisthoff, Robert Mandic iD

Cells · 2023

DOI: 10.3390/cells12121600 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2023. Verfasst von Li Xiang-Tischhauser und 10 weiteren Autor:innen. Beteiligte Einrichtung: VASCERN HHT Reference Centre, Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Marburg, Philipps-Universität Marburg, 35…. Hauptthemen laut MEDLINE: Induced Pluripotent Stem Cells, Telangiectasia, Hereditary Hemorrhagic. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research Campus of Central Hessen/Forschungscampus Mittelhessen, Open Acess Publishing Fund of Philipps-Universität Marburg.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hereditary hemorrhagic telangiectasia (HHT) type 2 is an autosomal dominant disease in which one allele of the ACVRL1 gene is mutated. Patients exhibit disturbances in TGF-beta/BMP-dependent angiogenesis and, clinically, often present with severe nosebleeds as well as a reduced quality of life. The aim of our study was to use CRISPR/Cas9 to knockout ACVRL1 in normal induced pluripotent stem cells (iPSCs) and evaluate the effects on TGF-beta- and BMP-related gene expression as well as angiogenesis. The CRISPR/Cas9 knockout of the ACVRL1 gene was carried out in previously characterized wild-type (ACVRL1wt/wt) iPSCs. An HHT type 2 iPS cell line was generated via a single-allele knockout (ACVRL1wt/mut) in wild-type (ACVRL1wt/wt) iPSCs, resulting in a heterozygous 17 bp frameshift deletion in the ACVRL1 gene [NG_009549.1:g.13707_13723del; NM_000020.3:c.1137_1153del]. After the generation of embryoid bodies (EBs), endothelial differentiation was induced via adding 4 ng/mL BMP4, 2% B27, and 10 ng/mL VEGF. Endothelial differentiation was monitored via immunocytochemistry. An analysis of 151 TGF-beta/BMP-related genes was performed via RT-qPCR through the use of mRNA derived from single iPS cell cultures as well as endothelial cells derived from EBs after endothelial differentiation. Differential TGF-beta/BMP gene expression was observed between ACVRL1wt/wt and ACVRL1wt/mut iPSCs as well as endothelial cells. EBs derived from CRISPR/Cas9-designed ACVRL1 mutant HHT type 2 iPSCs, together with their isogenic wild-type iPSC counterparts, can serve as valuable resources for HHT type 2 in vitro studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Induced Pluripotent Stem CellsTelangiectasia, Hereditary HemorrhagicHumansMutationEndothelial CellsQuality of LifeTransforming Growth Factor betaCell LineActivin Receptors, Type II

Stichwörter der Autor:innen

ACVRL1HHT2Morbus OsleriPSC

Substanzen

Transforming Growth Factor betaACVRL1 protein, humanActivin Receptors, Type II

Autor:innen und Institutionen

  • VASCERN HHT Reference Centre, Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Marburg, Philipps-Universität Marburg, 35033 Marburg, Germany.
  • Department of Molecular Neuroscience, Institute of Anatomy and Cell Biology, Philipps-Universität Marburg, 35037 Marburg, Germany.
  • Cellular Imaging Core Facility, Center for Tumor Biology and Immunology (ZTI), Philipps-Universität Marburg, 35043 Marburg, Germany.
  • Department of Oral- and Cranio-Maxillofacial Surgery, University Hospital Marburg, Philipps-Universität Marburg, 35043 Marburg, Germany.
  • Department of Histology and Developmental Biology, Tokyo Dental College, Tokyo 101-0061, Japan.
  • Department of Pharmaceutics and Biopharmaceutics, Philipps-Universität Marburg, 35037 Marburg, Germany.

ORCID-Profile: Li Xiang-Tischhauser, Michael Bette, Norio Kasahara, Udo Bakowsky, Robert Mandic

Förderung

  • Research Campus of Central Hessen/Forschungscampus Mittelhessen
  • Open Acess Publishing Fund of Philipps-Universität Marburg

Zitieren

APA

Xiang-Tischhauser, L., Bette, M., Rusche, J. R., Roth, K., Kasahara, N., Stuck, B. A., Bakowsky, U., Wartenberg, M., Sauer, H., Geisthoff, U. W., & Mandic, R. (2023). Generation of a Syngeneic Heterozygous ACVRL1(wt/mut) Knockout iPS Cell Line for the In Vitro Study of HHT2-Associated Angiogenesis. Cells. https://doi.org/10.3390/cells12121600

Vancouver

Xiang-Tischhauser L, Bette M, Rusche JR, Roth K, Kasahara N, Stuck BA, et al. Generation of a Syngeneic Heterozygous ACVRL1(wt/mut) Knockout iPS Cell Line for the In Vitro Study of HHT2-Associated Angiogenesis. Cells. 2023. doi:10.3390/cells12121600

BibTeX
@article{XiangTischhauser2023,
  author = {Xiang-Tischhauser, Li and Bette, Michael and Rusche, Johanna R and Roth, Katrin and Kasahara, Norio and Stuck, Boris A and Bakowsky, Udo and Wartenberg, Maria and Sauer, Heinrich and Geisthoff, Urban W and Mandic, Robert},
  title = {Generation of a Syngeneic Heterozygous ACVRL1(wt/mut) Knockout iPS Cell Line for the In Vitro Study of HHT2-Associated Angiogenesis},
  journal = {Cells},
  year = {2023},
  doi = {10.3390/cells12121600}
}
Kostenlos starten →